Literature DB >> 12417669

Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin.

Beth A Habecker1, Michael G Klein, Nathan C Sundgren, Wei Li, William R Woodward.   

Abstract

During development, sympathetic neurons innervating rodent sweat glands undergo a target-induced change in neurotransmitter phenotype from noradrenergic to cholinergic. Although the sweat gland innervation in the adult mouse is cholinergic and catecholamines are absent, these neurons continue to express tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. The developmental suppression of noradrenergic function in these mouse sympathetic neurons is not well understood. We investigated whether the downregulation of the enzyme aromatic l-amino acid decarboxylase (AADC) or the TH cofactor tetrahydrobiopterin (BH4) could account for the loss of catecholamines in these neurons. AADC levels did not decrease during development, and adult cholinergic sympathetic neurons were strongly immunoreactive for AADC. In contrast, BH4 levels dropped significantly in murine sweat gland-containing footpads during the time period when the gland innervation was switching from making norepinephrine to acetylcholine. Immunoreactivity for the rate-limiting BH4 synthetic enzyme GTP cyclohydrolase (GCH) became undetectable in the sweat gland neurons during this phenotypic conversion, suggesting that sweat glands reduce BH4 levels by suppressing GCH expression during development. Furthermore, extracts from sweat gland-containing footpads suppressed BH4 in cultured mouse sympathetic neurons, and addition of the BH4 precursor sepiapterin rescued catecholamine production in neurons treated with footpad extracts. Together, these results suggest that the mouse sweat gland-derived cholinergic differentiation factor functionally suppresses the noradrenergic phenotype during development by inhibiting production of the TH cofactor, BH4. These data also indicate that GCH expression, which is often coordinately regulated with TH expression, can be controlled independently of TH during development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417669      PMCID: PMC6758055     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  5 in total

1.  Infarction-induced cytokines cause local depletion of tyrosine hydroxylase in cardiac sympathetic nerves.

Authors:  Diana C Parrish; Eric N Alston; Hermann Rohrer; Paul Nkadi; William R Woodward; Günther Schütz; Beth A Habecker
Journal:  Exp Physiol       Date:  2009-10-30       Impact factor: 2.969

2.  Developmental expression of the high affinity choline transporter in cholinergic sympathetic neurons.

Authors:  G Guidry; B D Willison; R D Blakely; S C Landis; B A Habecker
Journal:  Auton Neurosci       Date:  2005-11-08       Impact factor: 3.145

3.  Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system.

Authors:  Eberhard Weihe; Burkhard Schütz; Wolfgang Hartschuh; Martin Anlauf; Martin K Schäfer; Lee E Eiden
Journal:  J Comp Neurol       Date:  2005-11-21       Impact factor: 3.215

4.  Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression.

Authors:  Eberhard Weihe; Candan Depboylu; Burkhard Schütz; Martin K-H Schäfer; Lee E Eiden
Journal:  Cell Mol Neurobiol       Date:  2006-05-31       Impact factor: 5.046

5.  Aging and the control of human skin blood flow.

Authors:  Lacy A Holowatz; Caitlin Thompson-Torgerson; W Larry Kenney
Journal:  Front Biosci (Landmark Ed)       Date:  2010-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.